This paper is in the following e-collection/theme issue:

Recruitment of Research Participants (246) Neurology and Neurosciences (106) Chronic Conditions (141) Research Infrastructures and Registries (32) Clinical Informatics (423) New Methods (616) Research Instruments, Questionnaires, and Tools (389) eHealth Infrastructures (199)

Published on in Vol 23, No 12 (2021): December

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/28021, first published .
Recruitment of Patients With Amyotrophic Lateral Sclerosis for Clinical Trials and Epidemiological Studies: Descriptive Study of the National ALS Registry’s Research Notification Mechanism

Recruitment of Patients With Amyotrophic Lateral Sclerosis for Clinical Trials and Epidemiological Studies: Descriptive Study of the National ALS Registry’s Research Notification Mechanism

Recruitment of Patients With Amyotrophic Lateral Sclerosis for Clinical Trials and Epidemiological Studies: Descriptive Study of the National ALS Registry’s Research Notification Mechanism

Authors of this article:

Paul Mehta 1 Author Orcid Image ;   Jaime Raymond 1 Author Orcid Image ;   Moon Kwon Han 1 Author Orcid Image ;   Theodore Larson 1 Author Orcid Image ;   James D Berry 2 Author Orcid Image ;   Sabrina Paganoni 2, 3 Author Orcid Image ;   Hiroshi Mitsumoto 4 Author Orcid Image ;   Richard Stanley Bedlack 5 Author Orcid Image ;   D Kevin Horton 1 Author Orcid Image
Article Authors Cited by Tweetations (4) Metrics
Paul Mehta 1, MD;  Jaime Raymond 1, MPH;  Moon Kwon Han 1, PhD, MPH, MSc;  Theodore Larson 1, MSc;  James D Berry 2, MD, MPH;  Sabrina Paganoni 2, 3, PhD, MD;  Hiroshi Mitsumoto 4, MD;  Richard Stanley Bedlack 5, PhD, MD;  D Kevin Horton 1, DrPH, MSPH

1 Agency for Toxic Substances and Disease Registry, Centers for Disease Control and Prevention , Atlanta, GA, US

2 Sean M Healey & AMG Center for ALS, Massachusetts General Hospital , Boston, MA, US

3 Spaulding Rehabilitation Hospital, Harvard Medical School , Boston, MA, US

4 Department of Neurology, Columbia University College of Physicians and Surgeons , New York City, NY, US

5 Department of Neurology, Duke University School of Medicine , Durham, NC, US

Corresponding Author:

  • Paul Mehta, MD
  • Agency for Toxic Substances and Disease Registry
  • Centers for Disease Control and Prevention
  • 4770 Buford Hwy NE
  • Atlanta, GA
  • US
  • Phone: 1 770-488-0556
  • Email: pum4@cdc.gov